| Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism SN Tchaikovski, M Thomassen, E Stickeler, K Bremme, J Rosing Thrombosis Research 207, 143-149, 2021 | 2 | 2021 |
| Severe thrombophilia in a factor V‐deficient patient homozygous for the Ala2086Asp mutation (FV Besançon) E Castoldi, N Hézard, G Mourey, K Wichapong, M Poggi, M Ibrahim‐Kosta, ... Journal of Thrombosis and Haemostasis 19 (5), 1186-1199, 2021 | 17 | 2021 |
| Negatively charged phospholipids stimulate factor XI activation by thrombin F Omarova, J Rosing, RM Bertina, E Castoldi Thrombosis Update 2, 100022, 2021 | 5 | 2021 |
| Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters J Douxfils, C Klipping, I Duijkers, V Kinet, M Mawet, C Maillard, M Jost, ... Contraception 102 (6), 396-402, 2020 | 87 | 2020 |
| Phospholipids and the clotting process RFA Zwaal, EM Bevers, J Rosing Phospholipid-Binding Antibodies, 31-56, 2020 | 4 | 2020 |
| Advances in understanding mechanisms of thrombophilic disorders B Dahlbäck Hämostaseologie 40 (01), 012-021, 2020 | 7 | 2020 |
| Development of a plasma-based assay to measure the susceptibility of factor v to inhibition by the C-terminus of TFPIα P van Doorn, J Rosing, E Campello, S Middeldorp, P Simioni, ... Thrombosis and haemostasis 120 (01), 055-064, 2020 | 5 | 2020 |
| Recombinant adeno-associated viral vectors expressing human coagulation FIX-E456H variant in hemophilia B mice S Le Quellec, AP Dane, E Barbon, JC Bordet, F Mingozzi, Y Dargaud, ... Thrombosis and Haemostasis 119 (12), 1956-1967, 2019 | 11 | 2019 |
| Estetrol is a unique native estrogen that does not modify coagulation markers in postmenopausal women and maintains sensitivity to activated protein C (APC) JM Foidart, RA Lobo, J Rosing, M Taziaux, M Jost, J Douxfils, U Gaspard | 5 | 2019 |
| Impact of deficiency of intrinsic coagulation factors XI and XII on ex vivo thrombus formation and clot lysis JWP Govers-Riemslag, J Konings, JMEM Cosemans, JP van Geffen, ... TH Open 3 (03), e273-e285, 2019 | 13 | 2019 |
| The C-terminus of tissue factor pathway inhibitor-a inhibits factor V activation by protecting the Arg (1545) cleavage site (vol 15, pg 140, 2017) P van Doorn, J Rosing, SJ Wielders, TM Hackeng, E Castoldi JOURNAL OF THROMBOSIS AND HAEMOSTASIS 17 (7), 1195-1195, 2019 | | 2019 |
| Estetrol combined with drospirenone: A new oral contraceptive with a favorable hemostatic profile [20OP] MD Creinin, J Rosing, M Jost, V Kinet, G Chatel, JM Foidart Obstetrics & Gynecology 133, 7, 2019 | 5 | 2019 |
| Development of a plasma-based assay to measure the susceptibility of factor V to inhibition by the TFPIα C-terminus P van Doorn, J Rosing, E Campello, S Middeldorp, P Simioni, ... Functional interactions between factor V and TFPI during onset of blood …, 2019 | | 2019 |
| A Plasma-Based Assay to Measure the Susceptibility of Factor V (a) to Inhibition By TFPIα TM Hackeng, P van Doorn, J Rosing, J Meijers, S Middeldorp, P Simioni, ... Blood 132, 1168, 2018 | | 2018 |
| The first intrinsic tenase complex inhibitor with serine protease structure offers a new perspective in anticoagulant therapy Z Latinović, A Leonardi, L Kovačič, CY Koh, J Šribar, AT Bakija, ... Thrombosis and Haemostasis 118 (10), 1713-1728, 2018 | 14 | 2018 |
| Factor V has anticoagulant activity in plasma in the presence of TFPIα: difference between FV1 and FV2 P Van Doorn, J Rosing, C Duckers, TM Hackeng, P Simioni, E Castoldi Thrombosis and Haemostasis 118 (07), 1194-1202, 2018 | 25 | 2018 |
| Suppressive role of tissue factor pathway inhibitor-α in platelet-dependent fibrin formation under flow is restricted to low procoagulant strength S Thomassen, TG Mastenbroek, F Swieringa, K Winckers, MAH Feijge, ... Thrombosis and haemostasis 118 (03), 502-513, 2018 | 19 | 2018 |
| Vitamin K–dependent protein S: beyond the protein C pathway B Dahlbäck Seminars in thrombosis and hemostasis 44 (02), 176-184, 2018 | 84 | 2018 |
| New functional assays to selectively quantify the activated protein C‐and tissue factor pathway inhibitor‐cofactor activities of protein S in plasma NA Alshaikh, J Rosing, M Thomassen, E Castoldi, P Simioni, TM Hackeng Journal of Thrombosis and Haemostasis 15 (5), 950-960, 2017 | 21 | 2017 |
| Endogenous thrombin potential changes during the first cycle of oral contraceptive use CL Westhoff, MC Pike, S Cremers, A Eisenberger, S Thomassen, ... Contraception 95 (5), 456-463, 2017 | 20 | 2017 |
